Skip to content

Clinical Significance of 64-slice Multidetector Coronary CT Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Renal Transplant Recipients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01753505
Enrollment
93
Registered
2012-12-20
Start date
2013-02-01
Completion date
2014-07-28
Last updated
2017-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant Recipient

Keywords

multidetector coronary CT angiography, renal transplantation

Brief summary

The aim of this study is to evaluate the clinical usefulness of 64-slice multidetector coronary CT angiography (MDCTA) in renal transplant recipients who had no previous coronary artery disease (CAD). Primary endpoint is to assess the prevalence and severity of coronary artery disease in patients post-transplant 6 to 12 months. CAD can be diagnosed noninvasively with similar accuracy of coronary angiography using MDCTA. Early detection and intervention of CAD may provide survival benefit in renal transplant recipients.

Interventions

OTHER64-slice Multidetector coronary CT angiography

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. age ≥ 40 yrs 2. renal transplant recipient at post-transplant 6 to 12 months 3. stable graft renal function: CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation ≥45 mL/min/1.75m2 4. patients who had no previous CAD

Exclusion criteria

1. unstable graft renal function 2. History of acute kidney injury within 3 months 3. Allergic history to contrast agent 4. Irregular heart beat 5. Multiorgan transplant recipients 6. Pregnancy 7. Patients who do not consent to this study

Design outcomes

Primary

MeasureTime frame
prevalence of coronary artery diseaseat post-transplant 6 to 12 months.

Secondary

MeasureTime frame
severity of coronary artery diseaseat post-transplant 6 to 12 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026